Business Information
The group's principal activity is to develop, manufacture and market instruments and consumables that are used to automate diagnostic and drug discovery procedures. The products of the group consist of tissue processors, staining systems and associated reagents. The group's renaissance tissue processor is a batch instrument that processes up to 350 specimens in a single run. The group's immunohistochemistry (ihc) staining systems include techmate 500 batch-processing instrument, nexes ihc staining system and the benchmark system. The in situ hybridization (ish) staining systems marketed by the group includes genii system and the discovery system. The group also offers a full line of consumable ancillary products necessary for processing slides. The group markets its products primarily in the United States, France, Germany, Japan and Australia.
|
|
Name |
Title
|
Email
|
| Jack Schuler | Chmn. | N/A | | John Patience | Vice Chmn. | N/A | | Christopher Gleeson | CEO, Pres. | N/A | | Lawrence Mehren | CFO, Sr. VP | N/A | | Thomas Grogan | Chmn. Emeritus, Chief Scientific Officer, Dir. - Medical, Sr. VP - Medical Affairs, Founder | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 238,223 | 31,578 | | 2005 | 199,132 | 25,488 | | 2004 | 166,102 | 21,289
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
